$ALCO
ALICO, INC.

2021 Q2 Form 10-Q Financial Statement

#000156459021041190 Filed on August 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $34.89M $26.12M
YoY Change 33.56% -54.62%
Cost Of Revenue $26.38M $19.90M
YoY Change 32.54% -36.94%
Gross Profit $8.510M $6.220M
YoY Change 36.82% -76.08%
Gross Profit Margin 24.39% 23.81%
Selling, General & Admin $1.911M $2.560M
YoY Change -25.35% -4.48%
% of Gross Profit 22.46% 41.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.732M $3.648M
YoY Change 2.3% 4.53%
% of Gross Profit 43.85% 58.65%
Operating Expenses $1.911M $2.560M
YoY Change -25.35% -4.48%
Operating Profit $6.599M $3.664M
YoY Change 80.1% -84.29%
Interest Expense -$907.0K -$1.600M
YoY Change -43.31% -8.57%
% of Operating Profit -13.74% -43.67%
Other Income/Expense, Net $29.39M -$1.405M
YoY Change -2191.6% -13.43%
Pretax Income $35.99M $2.259M
YoY Change 1493.01% -89.59%
Income Tax $8.853M $171.0K
% Of Pretax Income 24.6% 7.57%
Net Earnings $27.12M $2.096M
YoY Change 1193.85% -87.1%
Net Earnings / Revenue 77.73% 8.02%
Basic Earnings Per Share $3.61 $0.28
Diluted Earnings Per Share $3.61 $0.28
COMMON SHARES
Basic Shares Outstanding 7.521M 7.486M
Diluted Shares Outstanding 7.521M 7.493M

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.41M $80.40M
YoY Change -60.93% 2197.14%
Cash & Equivalents $31.41M $80.43M
Short-Term Investments
Other Short-Term Assets $2.460M $3.000M
YoY Change -18.0% -16.67%
Inventory $31.56M $29.25M
Prepaid Expenses
Receivables $6.484M $909.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $71.92M $113.6M
YoY Change -36.69% 157.49%
LONG-TERM ASSETS
Property, Plant & Equipment $370.1M $351.1M
YoY Change 5.43% 2.17%
Goodwill $2.246M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.765M $2.226M
YoY Change 24.21% -11.84%
Total Long-Term Assets $375.1M $356.3M
YoY Change 5.28% 0.26%
TOTAL ASSETS
Total Short-Term Assets $71.92M $113.6M
Total Long-Term Assets $375.1M $356.3M
Total Assets $447.1M $469.9M
YoY Change -4.87% 17.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.998M $4.503M
YoY Change 77.61% 4.28%
Accrued Expenses $8.558M $5.803M
YoY Change 47.48% -4.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $8.355M $5.130M
YoY Change 62.87% -3.66%
Total Short-Term Liabilities $32.88M $24.60M
YoY Change 33.63% 5.35%
LONG-TERM LIABILITIES
Long-Term Debt $122.1M $209.0M
YoY Change -41.6% 29.93%
Other Long-Term Liabilities $312.0K $246.0K
YoY Change 26.83% 0.0%
Total Long-Term Liabilities $122.4M $246.0K
YoY Change 49641.87% -99.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.88M $24.60M
Total Long-Term Liabilities $122.4M $246.0K
Total Liabilities $200.4M $265.2M
YoY Change -24.43% 22.64%
SHAREHOLDERS EQUITY
Retained Earnings $202.5M
YoY Change 11.26%
Common Stock $28.60M
YoY Change 1.51%
Preferred Stock
YoY Change
Treasury Stock (at cost) $30.00M $31.54M
YoY Change -4.87% -2.07%
Treasury Stock Shares $895.2K $930.0K
Shareholders Equity $246.7M $199.5M
YoY Change
Total Liabilities & Shareholders Equity $447.1M $469.9M
YoY Change -4.87% 17.62%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $27.12M $2.096M
YoY Change 1193.85% -87.1%
Depreciation, Depletion And Amortization $3.732M $3.648M
YoY Change 2.3% 4.53%
Cash From Operating Activities $7.978M $9.430M
YoY Change -15.4% -73.53%
INVESTING ACTIVITIES
Capital Expenditures -$5.420M -$6.990M
YoY Change -22.46% 46.23%
Acquisitions
YoY Change
Other Investing Activities $31.27M $390.0K
YoY Change 7918.21% 69.57%
Cash From Investing Activities $25.85M -$6.610M
YoY Change -491.09% 44.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -12.80M -5.690M
YoY Change 124.89% -79.78%
NET CHANGE
Cash From Operating Activities 7.978M 9.430M
Cash From Investing Activities 25.85M -6.610M
Cash From Financing Activities -12.80M -5.690M
Net Change In Cash 21.03M -2.870M
YoY Change -832.86% -198.29%
FREE CASH FLOW
Cash From Operating Activities $7.978M $9.430M
Capital Expenditures -$5.420M -$6.990M
Free Cash Flow $13.40M $16.42M
YoY Change -18.4% -59.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1724000
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
87000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2842000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7081000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-560000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33608000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15760000
alco Payments For Deposits On Purchase Of Productive Assets
PaymentsForDepositsOnPurchaseOfProductiveAssets
18230000
us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
453000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2020Q3 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
2057000
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
887000
CY2021Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1838000
CY2020Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2214000
CY2021Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
3760000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the date of the accompanying Financial Statements, the disclosure of contingent assets and liabilities in the Financial Statements and the accompanying Notes, and the reported amounts of revenues and expenses and cash flows during the periods presented. Actual results could differ from those estimates. The Company evaluates estimates on an ongoing basis. The estimates are based on current and expected economic conditions, historical experience, the experience and judgment of the Company’s management and various other specific assumptions that the Company believes to be reasonable.</p>
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
Receivables under contracts, whereby pricing is based on contractual and market prices, are primarily paid at the floor amount, and are collected within seven days after the harvest week. Any adjustments to pricing as a result of changes in market prices are collected or paid thirty to sixty days after final market pricing is published.
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34888000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26122000
alco Proceeds From Natural Disaster Relief
ProceedsFromNaturalDisasterRelief
493000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior year amounts have been reclassified in the accompanying Condensed Consolidated Financial Statements for consistent presentation to the current period. These reclassifications had no impact on net income, equity, cash flows or working capital as previously reported.</p>
CY2021Q2 us-gaap Assets
Assets
447067000
CY2021Q2 us-gaap Agricultural Related Inventory Growing Crops
AgriculturalRelatedInventoryGrowingCrops
30823000
CY2020Q3 us-gaap Agricultural Related Inventory Growing Crops
AgriculturalRelatedInventoryGrowingCrops
40265000
CY2021Q2 us-gaap Other Inventory
OtherInventory
741000
CY2020Q3 us-gaap Other Inventory
OtherInventory
590000
CY2021Q2 us-gaap Inventory Net
InventoryNet
31564000
CY2020Q3 us-gaap Inventory Net
InventoryNet
40855000
CY2020 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
4629000
CY2019 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
4629000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
370138000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
350061000
CY2020Q4 alco Long Lived Assets Acres Of Land Purchased
LongLivedAssetsAcresOfLandPurchased
3280
CY2020Q4 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
18230000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
8355000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
4285000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
4285000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
4285000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
4285000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
105940000
CY2021Q2 alco Long Term Debt And Line Of Credit
LongTermDebtAndLineOfCredit
131435000
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
907000
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1603000
us-gaap Interest Expense Debt
InterestExpenseDebt
3185000
us-gaap Interest Expense Debt
InterestExpenseDebt
4599000
CY2021Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
389000
CY2020Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
320000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1050000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
892000
CY2021Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
1296000
CY2020Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
1923000
us-gaap Interest Costs Incurred
InterestCostsIncurred
4235000
us-gaap Interest Costs Incurred
InterestCostsIncurred
5491000
CY2021Q2 alco Debt Instrument Covenant Minimum Debt Coverage Ratio
DebtInstrumentCovenantMinimumDebtCoverageRatio
1.10
CY2021Q2 alco Debt Instrument Covenant Minimum Tangible Net Worth
DebtInstrumentCovenantMinimumTangibleNetWorth
160000000
alco Debt Instrument Covenant Percentage Annual Increase
DebtInstrumentCovenantPercentageAnnualIncrease
0.10
alco Debt Instrument Covenant Minimum Tangible Networth Annual Increase
DebtInstrumentCovenantMinimumTangibleNetworthAnnualIncrease
169730000
CY2021Q2 alco Lineof Credit Facility Covenant Terms Minimum Current Ratio
LineofCreditFacilityCovenantTermsMinimumCurrentRatio
1.50
CY2021Q2 us-gaap Ratio Of Indebtedness To Net Capital1
RatioOfIndebtednessToNetCapital1
0.625
CY2021Q2 alco Debt Instrument Covenant Maximum Capital Expenditure
DebtInstrumentCovenantMaximumCapitalExpenditure
30000000
CY2021Q2 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1361000
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
1020000
CY2020Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
674000
CY2020Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
146000
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
280000
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
636000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
432000
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
348000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8558000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7095000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
27119000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2096000
us-gaap Net Income Loss
NetIncomeLoss
35831000
us-gaap Net Income Loss
NetIncomeLoss
6458000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7521000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7486000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7512000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7481000
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
12000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7521000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7493000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7512000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7493000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.61
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.61
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34888000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26122000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
104564000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87642000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
26378000
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
19902000
us-gaap Cost Of Revenue
CostOfRevenue
80431000
us-gaap Cost Of Revenue
CostOfRevenue
69191000
CY2021Q2 us-gaap Gross Profit
GrossProfit
8510000
CY2020Q2 us-gaap Gross Profit
GrossProfit
6220000
us-gaap Gross Profit
GrossProfit
24133000
us-gaap Gross Profit
GrossProfit
18451000
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3777000
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3648000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11485000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10847000
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
30779000
us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
28414
CY2020Q3 us-gaap Assets
Assets
423937000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
128000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
42000
us-gaap Operating Lease Cost
OperatingLeaseCost
392000
us-gaap Operating Lease Cost
OperatingLeaseCost
146000
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
87000
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M17D
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0320
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
222000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
666000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
175000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
530000
CY2019Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
7000
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
923621
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
775000
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
895207
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
30004000
CY2021Q2 us-gaap Purchase Obligation
PurchaseObligation
2110000

Files In Submission

Name View Source Status
0001564590-21-041190-index-headers.html Edgar Link pending
0001564590-21-041190-index.html Edgar Link pending
0001564590-21-041190.txt Edgar Link pending
0001564590-21-041190-xbrl.zip Edgar Link pending
alco-10q_20210630.htm Edgar Link pending
alco-10q_20210630_htm.xml Edgar Link completed
alco-20210630.xsd Edgar Link pending
alco-20210630_cal.xml Edgar Link unprocessable
alco-20210630_def.xml Edgar Link unprocessable
alco-20210630_lab.xml Edgar Link unprocessable
alco-20210630_pre.xml Edgar Link unprocessable
alco-ex311_8.htm Edgar Link pending
alco-ex312_7.htm Edgar Link pending
alco-ex321_9.htm Edgar Link pending
alco-ex322_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending